{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:36:21Z","timestamp":1781566581029,"version":"3.54.5"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T00:00:00Z","timestamp":1097107200000},"content-version":"vor","delay-in-days":9352,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[1979,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Three children with bullous erythema multiforme and 1 with toxic epidermal necrolysis associated with antiepileptic drug therapy are described. One patient is unique because of seven mucocutaneous eruptions caused by three classes of antiepileptic drugs. Lymphocyte stimulation by antiepileptic drugs could not be demonstrated in the 2 patients in whom appropriate studies were performed, and no precipitating antibodies to antiepileptic drugs were found. Observation of four diagnostic and therapeutic principles, which are illustrated by the course of our patients, may reduce the incidence of life\u2010threatening mucocutaneous eruptions and simplify the long\u2010term management of individuals in whom such reactions occur.<\/jats:p>","DOI":"10.1002\/ana.410050308","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T13:47:28Z","timestamp":1104587248000},"page":"262-267","source":"Crossref","is-referenced-by-count":28,"title":["Mucocutaneous eruptions due to antiepileptic drug therapy in children"],"prefix":"10.1002","volume":"5","author":[{"given":"Michael A.","family":"Pollack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,7]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1971.tb02545.x"},{"key":"e_1_2_1_3_2","first-page":"377","article-title":"Ocular aftermath of Stevens\u2010Johnson syndrome: review of 33 cases","volume":"90","author":"Arstikaitis MJ","year":"1973","journal-title":"Arch Ophthalmal"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2340\/0001555553149152","article-title":"Fifteen cases of toxic epidermal necrolysis","volume":"53","author":"Bjornberg A","year":"1973","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_1_5_2","volume-title":"Antiepileptic Drugs","author":"Booker HE","year":"1972"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5225.550"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1975.tb04746.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992287301201114"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.48.3.239"},{"key":"e_1_2_1_10_2","volume-title":"Antiepileptic Drugs","author":"Gallagher BG","year":"1972"},{"key":"e_1_2_1_11_2","first-page":"204","volume-title":"The Pharmacological Basis of Therapeutics","author":"Goodman LS","year":"1975"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(65)80189-5"},{"issue":"68","key":"e_1_2_1_13_2","article-title":"Cutaneous reactions to drugs","volume":"52","author":"Kauppinen K","year":"1972","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_1_14_2","first-page":"103","article-title":"Carbamazepine (Tegretol) in epilepsy","volume":"35","author":"Livingston S","year":"1974","journal-title":"Dis Nerv Syst"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1967.tb11434.x"},{"key":"e_1_2_1_16_2","first-page":"3","article-title":"Erythema multiforme: manifestations and management","volume":"8","author":"Lyell A","year":"1968","journal-title":"Curr Med Drugs"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1971.tb03915.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archderm.1974.01630050028006","article-title":"Dermal and epidermal types of erythema multiforme","volume":"109","author":"Orfanos CE","year":"1974","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_19_2","volume-title":"Handbook of Immunodiffusion and Immunoelectrophoresis","author":"Ouchterlony O","year":"1968"},{"key":"e_1_2_1_20_2","first-page":"87","article-title":"Continuous phenobarbital treatment after a \u201csimple febrile convulsion.\u201d","volume":"132","author":"Pollack MA","year":"1978","journal-title":"Am J Dis Child"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1976.tb00824.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archderm.1970.04000040084016","article-title":"Exanthem due to diphenylhydantoin therapy","volume":"101","author":"Robinson HM","year":"1970","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_23_2","first-page":"445","article-title":"An unusual dual hypersensitivity reaction induced by diphenylhydantoin","volume":"30","author":"Sisca TS","year":"1973","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_24_2","first-page":"508","article-title":"A rapid method for quantitation of the incorporation of H3 thymidine by lymphocytes in vitro","volume":"75","author":"Sorenson SF","year":"1969","journal-title":"Acta Pathol Microbiol Scand"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1973.tb07551.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-83-2-227"},{"key":"e_1_2_1_27_2","first-page":"222","volume-title":"Antiepileptic Drugs","author":"Woodbury DM","year":"1972"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(75)90507-0"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.410050308","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.410050308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T10:17:40Z","timestamp":1696673860000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.410050308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1979,3]]}},"alternative-id":["10.1002\/ana.410050308"],"URL":"https:\/\/doi.org\/10.1002\/ana.410050308","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,3]]}}}